MTOR and Alzheimer disease: While other reports have suggested either unaltered [48] or decreased [23] phospho-mTOR levels in APPSL/PSI KI mouse models of AD and following Aβ treatment in N2a cell lines respectively, an increase in mTOR phosphorylation has been reported in the AD brain [22,25].